Peter Werth Overview
- Firm
- Werth Ventures
- Primary Position
-
Founder & Chief...
- Primary Industry
-
Healthcare
- Active Board Seats
-
2
- Med. Deal Size
-
- Med. Valuation
-
Peter Werth General Information
Biography
Mr. Peter Werth is the Founder & served as Chief Executive Officer and President at Werth Ventures. Mr. Peter Werth serves as Board Member at Cingulate Therapeutics. He is the Owner & serves as the Chief Executive Officer & President at Chemwerth. He also serves as a board member at InnoPharma. He serves as Board Member at Alzeca Biosciences. From 1965 to 1975, he served in R & D for Upjohn Pharmaceuticals (now Pfizer). Before starting ChemWerth, he served as Vice President of Sales and Marketing of US operations with Ganes Chemicals, a subsidiary of Siegfried Chemicals. Mr. Werth is also a recognized philanthropist, establishing the Werth Family Foundation in 2001 to support higher education, children and human services, the arts and the environment. His philanthropy has touched the lives of thousands of people across the country and around the globe. Mr. Werth earned a BS degree in Chemistry and Math from Kansas State College, and an MS degree in Organic Chemistry from Stanford University.
Contact Information
Address
- 1764 Litchfield Turnpike
- Suite 202
- Woodbridge, CT 06525
- United States
Peter Werth Positions (3)
| Firm name | Firm type | Title | Location | Industry | Since |
|---|---|---|---|---|---|
| Alopexx | Investor | Director | Cambridge, MA | Family Office | |
| Chemwerth | Company | Founder | Woodbridge, CT | Other Pharmaceuticals and Biotechnology | |
| Werth Ventures | Investor | Founder & Chief Executive Officer | Woodbridge, CT | Investor |
Peter Werth Board Seats (2)
| Company | Industry | Ownership Status | Financing Status | Location | Since |
|---|---|---|---|---|---|
| Alzeca Biosciences | Biotechnology | Privately Held (backing) | Venture Capital-Backed | Houston, TX | |
| Cingulate | Pharmaceuticals | Publicly Held | Formerly VC-backed | Kansas City, KS |
Peter Werth Lead Partner on Deals (4)
| Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
|---|---|---|---|---|---|---|
| Cingulate | 11-Aug-2023 | PIPE | Completed | Pharmaceuticals | Kansas City, KS | |
| Bastion Health | 01-Oct-2020 | Completed | Other Healthcare Technology Systems | Farmington, CT | ||
| Cingulate | 16-Jan-2018 | Seed Round | Completed | Pharmaceuticals | Kansas City, KS | |
| Alzeca Biosciences | 17-Aug-2017 | Later Stage VC (Series A) | Completed | Biotechnology | Houston, TX |
Peter Werth Network (43)
Board Members (21)
| Name | Company | Representing | Location | From |
|---|---|---|---|---|
| Jeffrey Ervin | Cingulate | Self | Kansas City, KS | |
| Raman Kapur | InnoPharma | Self | Piscataway Township, NJ | |
| Cingulate | Cingulate | Kansas City, KS | ||
| Cingulate | Self | Kansas City, KS | ||
| Cingulate | Cingulate | Kansas City, KS |
Portfolio Executives (22)
| Name | Company | Role | Deal date | Location |
|---|---|---|---|---|
| Matthew Brams MD | Cingulate | Chief Medical Officer & Founder | 11-Aug-2023 | Kansas City, KS |
| Louis Van Horn | Cingulate | Chief Financial Officer | 11-Aug-2023 | Kansas City, KS |
| Cingulate | Co-Founder & Vice President, Business Development and Investor Relations | 11-Aug-2023 | Kansas City, KS | |
| Cingulate | Co-Founder & Board Member | 11-Aug-2023 | Kansas City, KS | |
| Cingulate | Co-Founder, General Counsel and Chief Compliance Officer | 11-Aug-2023 | Kansas City, KS |
Peter Werth FAQs
-
Who is Peter Werth?
Mr. Peter Werth is the Founder & served as Chief Executive Officer and President at Werth Ventures.
-
How much does Peter Werth typically invest?
Peter Werth's median deal size is .
-
What is Peter Werth’s main position?
Peter Werth’s primary position is Founder & Chief Executive Officer.
-
How many active board seats does Peter Werth hold?
Peter Werth holds 2 board seats including Alzeca Biosciences and Cingulate.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
